EMX2 is epigenetically silenced and suppresses growth in human lung cancer
1Department of Surgery, University of California, San Francisco, CA 94115, USA.
Abstract:
Lung cancer is a common cancer and the leading cause of cancer-related death worldwide. Aberrant activation of WNT signaling is implicated in lung carcinogenesis. EMX2, a human homologue of the Drosophila empty spiracles gene is a homeodomain-containing transcription factor. The function of EMX2 has been linked to the WNT signaling pathway during embryonic patterning in mice. However, little is known about the role of EMX2 in human tumorigenesis. In this study, we found that EMX2 was dramatically downregulated in lung cancer tissue samples and this downregulation was associated with methylation of the EMX2 promoter. Restoration of EMX2 expression in lung cancer cells lacking endogenous EMX2 expression suppressed cell proliferation and invasive phenotypes, inhibited canonical WNT signaling, and sensitized lung cancer cells to the treatment of the chemo cytotoxic drug cisplatin. On the other hand, knockdown of EMX2 expression in lung cancer cells expressing endogenous EMX2 promoted cell proliferation, invasive phenotypes and canonical WNT signaling. Taken together, our study suggests that EMX2 may have important roles as a novel suppressor in human lung cancer.
Insights
EMX2, a gene linked to embryonic development, acts as a tumor suppressor in lung cancer. Its downregulation promotes cancer cell growth and WNT signaling, suggesting EMX2 as a potential therapeutic target for lung cancer.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Lung cancer is a leading cause of cancer death globally.
- Aberrant WNT signaling is implicated in lung carcinogenesis.
- The role of EMX2 in human lung tumorigenesis is largely unknown.
Purpose of the Study:
- To investigate the role of EMX2 in human lung cancer.
- To determine the association between EMX2 expression and WNT signaling.
- To evaluate EMX2 as a potential therapeutic target in lung cancer.
Main Methods:
- Analysis of EMX2 expression and promoter methylation in lung cancer tissues.
- Restoration of EMX2 expression in EMX2-deficient lung cancer cells.
- Knockdown of EMX2 expression in EMX2-expressing lung cancer cells.
- Assessment of cell proliferation, invasion, and WNT signaling activity.
Main Results:
- EMX2 was significantly downregulated in lung cancer tissues, correlated with promoter methylation.
- Restoring EMX2 suppressed proliferation, invasion, and WNT signaling, enhancing cisplatin sensitivity.
- EMX2 knockdown promoted proliferation, invasion, and WNT signaling.
Conclusions:
- EMX2 functions as a tumor suppressor in human lung cancer.
- EMX2 downregulation is linked to aberrant WNT signaling and tumor progression.
- EMX2 represents a potential novel therapeutic target for lung cancer treatment.
Related Concept Videos
Epigenetic Regulation
Epigenetic Regulation
X-chromosome...
Abnormal Proliferation
Mitogens and the Cell Cycle
Inheritance of Chromatin Structures
Master Transcription Regulators

